Method of treating metabolic disorders using PLA2G12A polypeptides and PLA2G12A mutant polypeptides
US9474792B2 · kind B2 · utility
0Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2014 |
| Grant date | Oct 25, 2016 |
| Priority date | — |
| Expiry date | Mar 13, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/01004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating or ameliorating metabolic diseases using a PLA2G12A polypeptide or PLA2G12A mutant polypeptide are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes mellitus, obesity, dyslipidemia elevated glucose levels, elevated insulin levels and diabetic nephropathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.